Combinatorial Regimens | List of Frontiers open access articles

Review

Published on 11 Oct 2022

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment

in Inflammation Pharmacology

Jingyang Liu
Yang Yu
Cun Liu
Chundi Gao
Jing Zhuang
Lijuan Liu
Qibiao Wu
Wenzhe Ma
Qiming Zhang
Changgang Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1035954

4,862 views
11 citations

Mini Review

Published on 14 Jan 2026

Dissecting the MAPK signaling landscape in malignant melanoma: from BRAF and NRAS mutations to precision combination therapies

in Signaling

Xiaobo Fang
Shuangyin Wang
Shuangxing Fu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1723066

1,203 views

Review

Published on 18 Feb 2020

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

in Pediatric Oncology

Yoko Tabe
Marina Konopleva
Michael Andreeff

Frontiers in Oncology

doi 10.3389/fonc.2020.00155

17,225 views
73 citations

Review

Published on 29 Sep 2020

Microglia-Centered Combinatorial Strategies Against Glioblastoma

in Cancer Immunity and Immunotherapy

Tomás A. Martins
Philip Schmassmann
Tala Shekarian
Jean-Louis Boulay
Marie-Françoise Ritz
Steven Zanganeh
Johannes vom Berg
Gregor Hutter

Frontiers in Immunology

doi 10.3389/fimmu.2020.571951

11,749 views
28 citations

Review

Published on 09 Feb 2026

OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives

in Cancer Immunity and Immunotherapy

Yuehua Luo
Jing Li
Le Li
Bingbing Qin
Ruisheng Zhou
Ying Tang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1724756

590 views

Review

Published on 11 Sep 2020

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

in Epigenomics and Epigenetics

Lourdes Hontecillas-Prieto
Rocío Flores-Campos
Andrew Silver
Enrique de Álava
Nabil Hajji
Daniel J. García-Domínguez

Frontiers in Genetics

doi 10.3389/fgene.2020.578011

28,813 views
172 citations

Original Research

Published on 16 Sep 2025

Drug discovery for chemotherapeutic resistance based on pathway-responsive gene sets and its application in breast cancer

in Drug Discovery in Bioinformatics

Dehua Feng
Jingwen Hao
Lingxu Li
Jian Chen
Xinying Liu
Ruijie Zhang
Huirui Han
Tianyi Li
Xuefeng Wang
Xia Li

Frontiers in Bioinformatics

doi 10.3389/fbinf.2025.1661601

1,697 views

Mini Review

Published on 17 Oct 2025

The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology

in Gene and Cell Therapy

Yizhe Hu
Limei Leng
Bing Li
Qiang Qiao

Frontiers in Medicine

doi 10.3389/fmed.2025.1656570

4,105 views
1 citation

Original Research

Published on 23 Jan 2024

Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology

in Cardio-Oncology

V. Quagliariello
M. Passariello
I. Bisceglia
A. Paccone
A. Inno
C. Maurea
R. Rapuano Lembo
L. Manna
M. Iovine
M. L. Canale

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1232269

7,801 views
10 citations

Original Research

Published on 05 Jan 2023

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

in Cancer Endocrinology

Jingwei Lin
Yingxin Cai
Zuomin Wang
Yuxiang Ma
Jinyou Pan
Yangzhou Liu
Zhigang Zhao

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1005916

8,430 views
11 citations

Systematic Review

Published on 23 Jun 2022

Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis

in Cancer Immunity and Immunotherapy

Xin Zhao
Fengwei Gao
Jie Yang
Hua Fan
Qingyun Xie
Kangyi Jiang
Jie Gong
Benjian Gao
Qian Yang
Zehua Lei

Frontiers in Oncology

doi 10.3389/fonc.2022.877434

5,217 views
13 citations

Articles

Combinatorial regimens of chemotherapeutic agents: A new perspective on raising the heat of the tumor immune microenvironment

Dissecting the MAPK signaling landscape in malignant melanoma: from BRAF and NRAS mutations to precision combination therapies

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

Microglia-Centered Combinatorial Strategies Against Glioblastoma

OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials

Drug discovery for chemotherapeutic resistance based on pathway-responsive gene sets and its application in breast cancer

The advantages of NK cell vaccines in solid carcinoma clinical trials: conducted by various biology strategy and technology

Combinatorial immune checkpoint blockade increases myocardial expression of NLRP-3 and secretion of H-FABP, NT-Pro-BNP, interleukin-1β and interleukin-6: biochemical implications in cardio-immuno-oncology

Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer

Risk of Adverse Events in Cancer Patients Receiving Nivolumab With Ipilimumab: A Meta-Analysis